430 related articles for article (PubMed ID: 33837269)
21. Functional interventions as augmentation strategies for obsessive-compulsive disorder (OCD): scoping review and expert survey from the international college of obsessive-compulsive spectrum disorders (ICOCS).
Varinelli A; Caricasole V; Pellegrini L; Hall N; Garg K; Mpavaenda D; Dell'Osso B; Albert U; ; Fineberg NA
Int J Psychiatry Clin Pract; 2022 Mar; 26(1):92-107. PubMed ID: 33502269
[TBL] [Abstract][Full Text] [Related]
22. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
[TBL] [Abstract][Full Text] [Related]
23. Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis.
Hadi F; Kashefinejad S; Kamalzadeh L; Hoobehfekr S; Shalbafan M
BMC Pharmacol Toxicol; 2021 Nov; 22(1):69. PubMed ID: 34736541
[TBL] [Abstract][Full Text] [Related]
24. Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3β-dependent β-catenin/Wnt pathway activation.
Zhu Z; Yin J; Guan J; Hu B; Niu X; Jin D; Wang Y; Zhang C
FEBS J; 2014 Dec; 281(23):5371-89. PubMed ID: 25265417
[TBL] [Abstract][Full Text] [Related]
25. The Wnt/β-catenin signaling in endometriosis, the expression of total and active forms of β-catenin, total and inactive forms of glycogen synthase kinase-3β, WNT7a and DICKKOPF-1.
Pazhohan A; Amidi F; Akbari-Asbagh F; Seyedrezazadeh E; Farzadi L; Khodarahmin M; Mehdinejadiani S; Sobhani A
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():1-5. PubMed ID: 29107840
[TBL] [Abstract][Full Text] [Related]
26. Obsessive-Compulsive Symptoms in Obsessive-Compulsive Disorder and in Generalized Anxiety Disorder: Occurrence and Correlations.
Citkowska-Kisielewska A; Rutkowski K; Mielimąka M; Sobański JA; Dembińska E
J Psychiatr Pract; 2020 Mar; 26(2):101-119. PubMed ID: 32134883
[TBL] [Abstract][Full Text] [Related]
27. Hypoxic postconditioning activates the Wnt/β-catenin pathway and protects against transient global cerebral ischemia through Dkk1 Inhibition and GSK-3β inactivation.
Zhan L; Liu D; Wen H; Hu J; Pang T; Sun W; Xu E
FASEB J; 2019 Aug; 33(8):9291-9307. PubMed ID: 31120770
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanism of AQP3 in regulating differentiation and apoptosis of lung cancer stem cells through Wnt/GSK-3β/β-Catenin pathway.
Liu C; Liu L; Zhang Y; Jing H
J BUON; 2020; 25(4):1714-1720. PubMed ID: 33099905
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism of aquapontin (AQP3) in regulating differentiation and apoptosis of lung cancer stem cells through Wnt/GSK-3β/β-Catenin pathway.
Liu C; Liu L; Zhang Y; Jing H
J BUON; 2020; 25(2):828-834. PubMed ID: 32521874
[TBL] [Abstract][Full Text] [Related]
30. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
[TBL] [Abstract][Full Text] [Related]
31. Serum zonulin and claudin-5 levels in children with obsessive-compulsive disorder.
Işık Ü; Aydoğan Avşar P; Aktepe E; Doğuç DK; Kılıç F; Büyükbayram Hİ
Nord J Psychiatry; 2020; 74(5):346-351. PubMed ID: 31961248
[No Abstract] [Full Text] [Related]
32. Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions.
Kang BW; Kim F; Cho JY; Kim S; Rhee J; Choung JJ
Alzheimers Res Ther; 2022 Jul; 14(1):92. PubMed ID: 35804462
[TBL] [Abstract][Full Text] [Related]
33. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.
Berlin HA; Koran LM; Jenike MA; Shapira NA; Chaplin W; Pallanti S; Hollander E
J Clin Psychiatry; 2011 May; 72(5):716-21. PubMed ID: 20816027
[TBL] [Abstract][Full Text] [Related]
34. Clinical subtypes of obsessive-compulsive disorder based on the presence of checking and washing compulsions.
Fontenelle LF; Mendlowicz MV; Versiani M
Braz J Psychiatry; 2005 Sep; 27(3):201-7. PubMed ID: 16224607
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
36. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs.
Takahashi-Yanaga F; Sasaguri T
J Pharmacol Sci; 2009 Feb; 109(2):179-83. PubMed ID: 19179804
[TBL] [Abstract][Full Text] [Related]
37. Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways.
George MY; Menze ET; Esmat A; Tadros MG; El-Demerdash E
Life Sci; 2020 May; 249():117535. PubMed ID: 32151688
[TBL] [Abstract][Full Text] [Related]
38. EPRS/GluRS promotes gastric cancer development via WNT/GSK-3β/β-catenin signaling pathway.
Liu H; Fredimoses M; Niu P; Liu T; Qiao Y; Tian X; Chen X; Kim DJ; Li X; Liu K; Dong Z
Gastric Cancer; 2021 Sep; 24(5):1021-1036. PubMed ID: 33740160
[TBL] [Abstract][Full Text] [Related]
39. Circadian rhythms in obsessive-compulsive disorder.
Lange KW; Lange KM; Hauser J; Tucha L; Tucha O
J Neural Transm (Vienna); 2012 Oct; 119(10):1077-83. PubMed ID: 22543530
[TBL] [Abstract][Full Text] [Related]
40. BDNF-GSK-3β-β-Catenin Pathway in the mPFC Is Involved in Antidepressant-Like Effects of Morinda officinalis Oligosaccharides in Rats.
Xu LZ; Xu DF; Han Y; Liu LJ; Sun CY; Deng JH; Zhang RX; Yuan M; Zhang SZ; Li ZM; Xu Y; Li JS; Xie SH; Li SX; Zhang HY; Lu L
Int J Neuropsychopharmacol; 2017 Jan; 20(1):83-93. PubMed ID: 27729466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
